PRP Services Private Limited Revenue and Competitors

Location

N/A

Total Funding

Telecom

Industry

Estimated Revenue & Valuation

  • PRP Services Private Limited's estimated annual revenue is currently $33.1M per year.(i)
  • PRP Services Private Limited's estimated revenue per employee is $325,000

Employee Data

  • PRP Services Private Limited has 102 Employees.(i)

PRP Services Private Limited's People

NameTitleEmail/Phone
1
Sales ExecutiveReveal Email/Phone
2
Lead Generation SpecialistReveal Email/Phone
3
Sales ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$776.2M1706-6%$200M$2.7B
#2
$10.4M40N/AN/AN/A
#3
$9.1M37-3%$15MN/A
#4
$87.9M246N/AN/AN/A
#5
$31.9M200N/AN/AN/A
#6
$228.8M0N/A$254.7MN/A
#7
$0.1M5-44%$1.6MN/A
#8
$0.8M567%N/AN/A
#9
$1.4M190%$254.7MN/A
#10
$84.3M45822%$2MN/A
#11
$16.7M57N/AN/AN/A
#12
$17.3M59N/AN/AN/A
#13
$8.7M67N/AN/AN/A
#14
$574.7M1263N/AN/AN/A
#15
$33.2M102N/AN/AN/A
#16
$356.2M1718-2%$322.1MN/A
#17
$1M12N/AN/AN/A
#18
$186.1M61411%$98.4M$459.6M
#19
$18.1M62N/AN/AN/A
#20
$30.1M1933%$10MN/A
Add Company

What Is PRP Services Private Limited?

keywords:N/A

N/A

Total Funding

102

Number of Employees

$33.1M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

PRP Services Private Limited News

2022-04-17 - Explosive growth on Platelet Rich Plasma Market 2022-2029 ...

Although PRP is a major component of platelets, other cellular components such as White Blood Cells ... Johnson & Johnson Private Limited.

2022-04-17 - Platelet Rich Plasma Market Dynamics, Comprehensive ...

Global Platelet Rich Plasma market report provides best solutions for ... Cascade Medical, Grifols, S.A., Johnson & Johnson Private Limited.

2022-04-17 - Platelet Rich Plasma Market Research Report 2022, Size ...

... DR PRP USA LLC, Isto Biologics, Arthrex, Inc., Terumo Corporation, Cascade Medical, Grifols, S.A., Johnson & Johnson Private Limited.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.3M1024%N/A
#2
$17.7M102-3%N/A
#3
N/A10238%N/A
#4
$20.5M102-4%N/A
#5
N/A10327%N/A